Evolent Net Debt from 2010 to 2024

EVH Stock

USD 13.26 1.05 8.60%

Evolent Health's Net Debt is increasing with slightly volatile movements from year to year. Net Debt is estimated to finish at about 474.6 M this year. Net Debt is the total debt of Evolent Health minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2013-12-31

Previous Quarter

698.6 M

Current Value

538.6 M

Quarterly Volatility

238.5 M

Yuan Drop

Covid

Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.6 M, Total Revenue of 2.1 B or Gross Profit of 483.5 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0072 or PTB Ratio of 3.61. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.

Check out the analysis of Evolent Health Correlation against competitors.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Latest Evolent Health's Net Debt Growth Pattern

Below is the plot of the Net Debt of Evolent Health over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Evolent Health's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Evolent Net Debt Regression Statistics

	Arithmetic Mean	66,801,837
	Coefficient Of Variation	304.39
	Mean Deviation	162,004,960
	Median	(5,252,000)
	Standard Deviation	203,339,173
	Sample Variance	41346.8T
	Range	620.3M
	R-Value	0.72
	Mean Square Error	21146.4T
	R-Squared	0.53
	Significance	0
	Slope	32,947,617
	Total Sum of Squares	578855.5T

Evolent Net Debt History

	2024	474.6 M
	2023	452 M
	2022	287.9 M
	2021	14.2 M
	2020	19.3 M
	2019	267.8 M
	2018	-7.3 M

Other Fundumenentals of Evolent Health

Net Debt To E B I T D A

Evolent Health Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Current Deferred Revenue	Short Term Investments	Short Term Debt	Property Plant Equipment	Net Tangible Assets	Long Term Debt	Good Will	Deferred Long Term Liab	Long Term Investments	Common Stock	Capital Surpluse	Long Term Debt Total	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.86	0.76	-0.64	0.61	0.87	0.92	0.85	0.98	-0.48	0.24	-0.01	0.8	-0.57	0.82	0.45	-0.65	-0.27	0.92	0.85	0.76	-0.8	0.56	0.54	-0.8	0.76
Total Stockholder Equity	0.86		0.44	-0.32	0.74	0.52	0.62	0.84	0.74	-0.05	0.3	0.27	0.79	-0.25	0.48	0.35	-0.55	-0.15	0.94	0.79	0.61	-0.66	0.49	0.42	-0.55	0.45
Net Debt	0.76	0.44		-0.77	0.21	0.89	0.89	0.5	0.85	-0.69	-0.12	-0.53	0.64	-0.68	0.95	0.54	-0.56	0.0	0.58	0.7	0.83	-0.72	0.19	0.65	-0.9	0.86
Retained Earnings	-0.64	-0.32	-0.77		-0.27	-0.8	-0.85	-0.66	-0.7	0.77	-0.13	0.59	-0.77	0.5	-0.85	-0.16	0.77	0.23	-0.58	-0.81	-0.8	0.81	-0.59	-0.22	0.89	-0.81
Accounts Payable	0.61	0.74	0.21	-0.27		0.32	0.44	0.71	0.49	-0.01	0.31	0.25	0.65	-0.06	0.32	0.18	-0.22	-0.3	0.67	0.63	0.38	-0.66	0.54	0.23	-0.34	0.23
Net Receivables	0.87	0.52	0.89	-0.8	0.32		0.98	0.67	0.95	-0.77	0.12	-0.28	0.66	-0.72	0.96	0.57	-0.6	-0.36	0.67	0.75	0.79	-0.7	0.47	0.63	-0.84	0.94
Total Liab	0.92	0.62	0.89	-0.85	0.44	0.98		0.77	0.97	-0.71	0.14	-0.29	0.78	-0.66	0.96	0.47	-0.68	-0.3	0.77	0.84	0.83	-0.82	0.56	0.56	-0.89	0.9
Total Current Assets	0.85	0.84	0.5	-0.66	0.71	0.67	0.77		0.78	-0.36	0.32	0.03	0.9	-0.36	0.63	0.29	-0.67	-0.43	0.93	0.92	0.75	-0.8	0.79	0.32	-0.65	0.65
Intangible Assets	0.98	0.74	0.85	-0.7	0.49	0.95	0.97	0.78		-0.59	0.18	-0.11	0.75	-0.66	0.91	0.55	-0.62	-0.3	0.83	0.81	0.79	-0.76	0.49	0.63	-0.83	0.86
Current Deferred Revenue	-0.48	-0.05	-0.69	0.77	-0.01	-0.77	-0.71	-0.36	-0.59		0.07	0.5	-0.38	0.81	-0.73	-0.36	0.36	0.3	-0.32	-0.47	-0.67	0.52	-0.25	-0.37	0.7	-0.84
Short Term Investments	0.24	0.3	-0.12	-0.13	0.31	0.12	0.14	0.32	0.18	0.07		0.31	0.18	0.04	-0.01	-0.17	-0.4	-0.45	0.33	0.23	-0.09	-0.02	0.37	-0.27	-0.1	0.08
Short Term Debt	-0.01	0.27	-0.53	0.59	0.25	-0.28	-0.29	0.03	-0.11	0.5	0.31		-0.19	0.19	-0.42	0.01	0.33	-0.23	0.07	-0.23	-0.37	0.32	0.03	-0.04	0.5	-0.38
Property Plant Equipment	0.8	0.79	0.64	-0.77	0.65	0.66	0.78	0.9	0.75	-0.38	0.18	-0.19		-0.28	0.72	0.23	-0.78	-0.09	0.89	0.98	0.87	-0.92	0.64	0.32	-0.82	0.64
Net Tangible Assets	-0.57	-0.25	-0.68	0.5	-0.06	-0.72	-0.66	-0.36	-0.66	0.81	0.04	0.19	-0.28		-0.65	-0.53	0.18	0.36	-0.42	-0.39	-0.61	0.36	-0.04	-0.52	0.56	-0.78
Long Term Debt	0.82	0.48	0.95	-0.85	0.32	0.96	0.96	0.63	0.91	-0.73	-0.01	-0.42	0.72	-0.65		0.54	-0.61	-0.2	0.63	0.78	0.84	-0.78	0.41	0.64	-0.89	0.91
Good Will	0.45	0.35	0.54	-0.16	0.18	0.57	0.47	0.29	0.55	-0.36	-0.17	0.01	0.23	-0.53	0.54		0.06	-0.21	0.27	0.32	0.53	-0.18	-0.11	0.97	-0.3	0.66
Deferred Long Term Liab	-0.65	-0.55	-0.56	0.77	-0.22	-0.6	-0.68	-0.67	-0.62	0.36	-0.4	0.33	-0.78	0.18	-0.61	0.06		0.05	-0.73	-0.8	-0.63	0.67	-0.6	-0.01	0.78	-0.56
Long Term Investments	-0.27	-0.15	0.0	0.23	-0.3	-0.36	-0.3	-0.43	-0.3	0.3	-0.45	-0.23	-0.09	0.36	-0.2	-0.21	0.05		-0.22	-0.21	-0.08	0.03	-0.59	-0.07	-0.04	-0.34
Common Stock	0.92	0.94	0.58	-0.58	0.67	0.67	0.77	0.93	0.83	-0.32	0.33	0.07	0.89	-0.42	0.63	0.27	-0.73	-0.22		0.91	0.75	-0.8	0.61	0.34	-0.73	0.62
Capital Surpluse	0.85	0.79	0.7	-0.81	0.63	0.75	0.84	0.92	0.81	-0.47	0.23	-0.23	0.98	-0.39	0.78	0.32	-0.8	-0.21	0.91		0.9	-0.91	0.65	0.39	-0.85	0.75
Long Term Debt Total	0.76	0.61	0.83	-0.8	0.38	0.79	0.83	0.75	0.79	-0.67	-0.09	-0.37	0.87	-0.61	0.84	0.53	-0.63	-0.08	0.75	0.9		-0.83	0.38	0.6	-0.87	0.87
Short Long Term Debt	-0.8	-0.66	-0.72	0.81	-0.66	-0.7	-0.82	-0.8	-0.76	0.52	-0.02	0.32	-0.92	0.36	-0.78	-0.18	0.67	0.03	-0.8	-0.91	-0.83		-0.6	-0.31	0.87	-0.64
Cash And Equivalents	0.56	0.49	0.19	-0.59	0.54	0.47	0.56	0.79	0.49	-0.25	0.37	0.03	0.64	-0.04	0.41	-0.11	-0.6	-0.59	0.61	0.65	0.38	-0.6		-0.1	-0.37	0.36
Net Invested Capital	0.54	0.42	0.65	-0.22	0.23	0.63	0.56	0.32	0.63	-0.37	-0.27	-0.04	0.32	-0.52	0.64	0.97	-0.01	-0.07	0.34	0.39	0.6	-0.31	-0.1		-0.41	0.67
Net Working Capital	-0.8	-0.55	-0.9	0.89	-0.34	-0.84	-0.89	-0.65	-0.83	0.7	-0.1	0.5	-0.82	0.56	-0.89	-0.3	0.78	-0.04	-0.73	-0.85	-0.87	0.87	-0.37	-0.41		-0.83
Capital Stock	0.76	0.45	0.86	-0.81	0.23	0.94	0.9	0.65	0.86	-0.84	0.08	-0.38	0.64	-0.78	0.91	0.66	-0.56	-0.34	0.62	0.75	0.87	-0.64	0.36	0.67	-0.83

Click cells to compare fundamentals

About Evolent Health Financial Statements

Investors use fundamental indicators, such as Evolent Health's Net Debt, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Net Debt	452 M	474.6 M
Net Debt To EBITDA	(18.24)	(17.32)

Currently Active Assets on Macroaxis

ESRT	Empire State Realty
C	Citigroup
C	Citigroup
GOOG	Alphabet Inc Class C
DD	Dupont De Nemours

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:

How To Invest In Evolent

Details

Is Evolent Stock a good investment?

Details

What is Evolent Health's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Evolent Health Correlation against competitors.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

21.554

Quarterly Revenue Growth

0.216

Return On Assets

0.0073

Return On Equity

(0.06)

The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evolent Net Debt from 2010 to 2024

Latest Evolent Health's Net Debt Growth Pattern

Evolent Net Debt Regression Statistics

Evolent Net Debt History

Other Fundumenentals of Evolent Health

Evolent Health Net Debt component correlations

About Evolent Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY